FDA approves new drug for rare form of ALS

(WASHINGTON) -- The U.S. Food and Drug Administration approved a new drug Tuesday to treat a rare form of amyotrophic lateral sclerosis, or ALS.The drug Qalsody (tofersen) is expected to help people with a very specific mutation, SOD1, which applies to only 2% of the... Read More.